Acadia Pharmaceuticals Inc. ACAD
$20.68
-6.76%
at last close
Financials (TTM)
- Revenue
- $1.14 billion
- Net Income
- $380.48 million
- Net Margin
- 33.42%
- Return on Equity
- 29.12%
- Debt-to-Equity
- —
- P/E Ratio
- 9.27
- Price / Book
- 2.73
- Price / Sales
- 3.13
Over the trailing twelve months, Acadia Pharmaceuticals Inc. generated revenue of $1.14 billion and net income of $380.48 million, a net margin of 33.42%.
At the last closing price of $20.68, ACAD trades at 9.27 times trailing earnings and 3.13 times sales, with a market capitalization of $3.56 billion.
Key Stats
- Last Close
- $20.68
- Market Cap
- $3.56 billion
- 52-Week Range
- $19.69 – $30.96
- Average Volume
- 1.76 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.